文献速递神经核医学肿瘤 PET/CT

纹状体多巴胺转运体摄取可预测帕金森病的神经元低代谢和视空间功能

Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-02-14

研究纳入62例帕金森病患者和33名健康对照,行FP-CIT PET/CT、FDG PET/CT及神经心理测试。结果显示壳核前部与后部DAT摄取与低代谢区平均SUVR正相关,壳核前部及尾状核DAT摄取降低与视空间功能z分数降低相关;事件模型提示壳核后部与前部DAT摄取降低最先出现,随后为脑低代谢和视空间功能改变。

要点

  • 帕金森病患者壳核前部和后部DAT摄取与低代谢区平均SUVR正相关。
  • 壳核前部及尾状核DAT摄取降低与视空间功能z分数降低相关。
  • 事件模型提示壳核后部与前部DAT摄取降低最先出现,随后为脑低代谢和视空间功能改变。

核心结论

  • 本研究强调多巴胺能耗竭、脑葡萄糖低代谢与视空间功能障碍相互关联,提出纹状体DAT摄取可能作为帕金森病脑低代谢和认知损害的早期生物标志物。

研究设计与样本

  • 研究纳入62例帕金森病患者和33名健康对照,受试者接受FP-CIT PET/CT、FDG PET/CT和详细神经心理测试。
  • 将帕金森病患者中代谢显著降低区域的平均标准摄取值比值定义为SUVR[hypo]。
  • 采用一般线性模型评估纹状体DAT摄取与SUVR[hypo]的关系,采用多因素线性回归评估二者对认知功能的影响,并采用事件模型评估其变化模式。

主要发现

  • 与对照组相比,帕金森病患者在特定皮质区域表现出葡萄糖低代谢。
  • 壳核前部和后部的DAT摄取与SUVR[hypo]呈正相关。
  • 壳核前部和尾状核DAT摄取降低与视空间功能z分数降低相关。
  • 事件模型显示壳核后部和前部DAT摄取降低最先出现,随后为帕金森病相关脑低代谢和视空间功能改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: While many studies have explored the link between biomarkers and cognitive decline in Parkinson's disease (PD), a more comprehensive approach is needed, combining striatal dopamine depletion, cerebral glucose metabolism, and cognitive assessments. In this study, we investigated the relationships between striatal dopamine transporter (DAT) uptake, cerebral glucose hypometabolism, and cognition, as well as the potential progression pattern of these changes in PD. METHODS: We enrolled 62 patients with PD and 33 healthy controls. The subjects underwent N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane (FP-CIT) PET/CT, [18F] fluorodeoxyglucose (FDG) PET/CT, and detailed neuropsychological testing. The mean standard uptake value ratio (SUVR) value of the regions showing significantly lower metabolism in PD patients was defined as SUVR[hypo]. The relationship between striatal DAT uptake and SUVR[hypo] was assessed using general linear models, while their impact on cognitive function was evaluated with multivariate linear regression. Additionally, the pattern of their changes was assessed using an event-based model. RESULTS: Compared to the control group, PD patients exhibited glucose hypometabolism in specific cortical regions. DAT uptake in the anterior and posterior putamen was positively correlated with SUVR[hypo]. Decreased DAT uptake in the anterior putamen and caudate nucleus was associated with lower z-score in visuospatial function. Decreased DAT uptake in the posterior and anterior putamen occurred first, followed by PD-related cerebral hypometabolism, and visuospatial function. CONCLUSION: This study highlights the interconnectedness of dopaminergic depletion, cerebral glucose hypometabolism, and visuospatial dysfunction, proposing that striatal DAT uptake may serve as an early biomarker for cerebral hypometabolism and cognitive impairment in PD.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Seo S, Yoon YJ, Lee S, et al. Striatal dopamine transporter uptake predicts neuronal hypometabolism and visuospatial function in Parkinson's disease. Eur J Nucl Med Mol Imaging. 2025. PMID: 39951136. doi:10.1007/s00259-025-07137-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。